Skip to content

Ayurvedic management of amavata (Rheumatoid arthritis)

A clinical study of vardhamana pippali kalpa in the management of amavata vis-a-vis rheumatoid arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/11/007510
Enrollment
30
Registered
2016-11-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- amavata (rheumatoid arthritis)

Interventions

Intervention1: Ayurvedic classical herbal formulation: Pippali churna in vardhmana krama,i.e. starting the dose from 1 gm on the first day, twice a day with hot water will given. It will be increased

Sponsors

J S ayurveda college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Presence of sandhiÅ?ula (pain in joints), sandhijÄ?dyatÄ? (stiffness in joints), sandhisotha (swelling in joints), restriction of movement. 2.Presence of any six out of the following ten classification criteria and European league against rheumatism (EULAR).

Exclusion criteria

Exclusion criteria: 1.Patients who have developed complications of rheumatoid arthritis e.g. Severe deformity of joints ones, pleura-pericardial disease, or else. 2.Association of a joint disease of other origin. 3.Patients having HbA1c above 7.5 of diabetes mellitus. 4.Patients on prolonged medication with immunosuppressive e.g. corticosteroids any other drugs within last 6 months that may have an influence on the outcome of the study. 5.Pregnant/lactating women.

Design outcomes

Primary

MeasureTime frame
effect of the vardhamana pippali kalpa in the patients of amavataTimepoint: Grade score of signs and symptoms

Secondary

MeasureTime frame
NILTimepoint: Not Applicable

Countries

India

Contacts

Public ContactManisha T Parmar

J S Ayurveda college and P D patel ayurveda hospital Nadiad

manishayu97@yahoo.com9979589865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026